🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.06
-0.14 (-1.88%)
Nov 20, 2026, 11:22 AM EST - Market open

MRVI Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, MRVI stock has a consensus rating of "Buy" and an average price target of $9.64. The average 1-year stock price forecast is 36.68% higher than the current stock price, while the lowest is $8.00 (+13.39%) and the highest is $12 (+70.09%).

Price Target: $9.64 (+36.68%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$9.64$9.50$12
Change+13.39%+36.68%+34.66%+70.09%

Analyst Ratings

The average analyst rating for MRVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy555456
Buy000000
Hold333443
Sell000000
Strong Sell000000
Total888899

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
KeyBanc
KeyBanc
Buy
Upgrades
$11
BuyUpgrades$11+55.92%Nov 12, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$7 → $10
BuyMaintains$7 → $10+41.74%Nov 5, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$8 → $9.5
BuyMaintains$8 → $9.5+34.66%Nov 5, 2026
TD Cowen
TD Cowen
Buy
Initiates
$9
BuyInitiates$9+27.57%Oct 5, 2026
Unknown Analyst
UBS
No rating
UBS
Hold
Initiates
$2.5 → $8
HoldInitiates$2.5 → $8+13.39%Sep 9, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
214.30M
from 185.74M
Increased by 15.38%
Revenue Next Year
224.56M
from 214.30M
Increased by 4.79%
EPS This Year
-0.07
from -0.29
EPS Next Year
-0.08
from -0.07
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
799.24M883.00M288.95M259.19M185.74M214.30M
Revenue Growth
181.33%10.48%-67.28%-10.30%-28.34%15.38%
Operating Income
543.40M569.92M-28.47M-72.68M-125.63M-3.73M
Net Income
182.04M220.21M-119.03M-144.85M-130.77M-49.95M
EPS
-----0.29-0.07
Free Cash Flow
-----70.72M11.40M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High215.2M
Avg214.3M
Low212.5M

Revenue Growth

Revenue Growth202620272028
High
15.9%
Avg
15.4%
Low
14.4%

EPS Forecast

EPS202620272028
High-0.05
Avg-0.07
Low-0.09

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-